CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Plethora Solutions Holdings plc (OLD) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Plethora Solutions Holdings plc (OLD)
Hampden House
Monument Business Pk.
Phone: +44 2030775400p:+44 2030775400 London, OX44 7RW  United Kingdom Ticker: PLEPLE
This company was Merged or Acquired on 3/9/2016.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Plethora Solutions Holdings plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical treatments for premature ejaculation in the area of men's sexual health. The Company is engaged in the development of new pharmaceutical products, which it refers to as Plethora Development. The Company has developed PSD502, which is a treatment for premature ejaculation, and has also completed phase III clinical trials. The PSD502 is also authorized to be marketed under the name of Prilocaine Lidocaine Plethora through the European Medicines Agency (EMA). Its subsidiaries include Plethora Solutions Limited and Plethora Therapeutics Limited.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201512/31/2014Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board JamesMellon 57 4/12/2013 1/6/2012
Chief Executive Officer, Executive Director Jamie AlexanderGibson 49 1/1/2014 1/1/2014
Chief Financial Officer Colin J.Kunz 6/1/2015 6/1/2015
4 additional Officers and Directors records available in full report.

Business Names
Business Name
PLE
Plethora Solutions Holdings plc
Plethora Solutions Limited
The Urology Company Holdings Limited

General Information
Number of Employees: 5 (As of 12/31/2014)
Outstanding Shares: 823,297,686 (As of 11/4/2015)
Stock Exchange: SEA
Fax Number: +44 2030775440


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023